Newsletter
In this section, you will find the lastest news about our products
UltraGRO™-PURE GI and Exosome-Depleted UltraGRO™-PURE GI are premium cell culture supplements designed to replace fetal bovine serum (FBS) for enhanced cell expansion, supporting various research, clinical, and commercial applications. Both products are gamma-irradiated, xeno-free, and viral-inactivated, making them ideal for high-quality cell culture requirements.
UltraGRO™-PURE...
 |
Oncomedics Group announces its plans for 2024, including the launch of the Oncotarget kit for the study of solid tumors, as well as advances in clinical studies of metastatic colorectal cancer. They also strengthen their market presence by partnering with Genexpath for sarcoma and lymphoma diagnostics, affirming their commitment to innovation and medical advancement.
|
Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.
|